Whole exome sequencing identified a novel compound heterozygous mutation of nephrocystin 4 in a child with nephronophthisis—a rare case report - Scorecard - MDSpire
Advertisement
Whole exome sequencing identified a novel compound heterozygous mutation of nephrocystin 4 in a child with nephronophthisis—a rare case report
Clinical Scorecard: Identification of a Novel Compound Heterozygous Nephrocystin 4 Mutation in a Pediatric Case of Nephronophthisis Through Whole Exome Sequencing
At a Glance
Category
Detail
Condition
Nephronophthisis
Key Mechanisms
Autosomal recessive disorder characterized by chronic tubulointerstitial nephritis and defects in primary cilia.
Target Population
Pediatric patients with nephronophthisis.
Care Setting
Clinical genetic testing and pediatric nephrology.
Key Highlights
Nephronophthisis is the most prevalent monogenic cause of end-stage renal disease.
A novel compound heterozygous mutation in the NPHP4 gene was identified.
The patient presented with typical symptoms including edema, proteinuria, and renal dysfunction.
Genetic testing confirmed pathogenic variants in the NPHP4 gene.
The condition improved with a combination of medications.
Guideline-Based Recommendations
Diagnosis
Utilize whole exome sequencing for genetic diagnosis of nephronophthisis.
Management
Consider treatment with immunosuppressants and supportive care for renal dysfunction.
Monitoring & Follow-up
Regular monitoring of renal function and proteinuria levels.
Risks
Risk of progression to end-stage renal disease if not managed appropriately.
Patient & Prescribing Data
Pediatric patients diagnosed with nephronophthisis.
Combination therapy including prednisone, tacrolimus, and supportive supplements showed improvement.
Clinical Best Practices
Early genetic testing in pediatric patients with symptoms of nephronophthisis.
Multidisciplinary approach involving nephrologists and geneticists.
